CID 3221

Emorfazone

Structural Information

Molecular Formula
C11H17N3O3
SMILES
CCOC1=C(C=NN(C1=O)C)N2CCOCC2
InChI
InChI=1S/C11H17N3O3/c1-3-17-10-9(8-12-13(2)11(10)15)14-4-6-16-7-5-14/h8H,3-7H2,1-2H3
InChIKey
URJQOOISAKEBKW-UHFFFAOYSA-N
Compound name
4-ethoxy-2-methyl-5-morpholin-4-ylpyridazin-3-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

31
References

6524
Patents

239.127 Da
Monoisotopic Mass

0.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 240.13428 154.1
[M+Na]+ 262.11622 167.3
[M+NH4]+ 257.16082 160.4
[M+K]+ 278.09016 162.0
[M-H]- 238.11972 156.9
[M+Na-2H]- 260.10167 159.7
[M]+ 239.12645 156.6
[M]- 239.12755 156.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe